@AaronGoodman33 No OS benefit but DEC overcome bad effect of TP53 mutation https://t.co/whxlKc5lLp
So far, Altmetric has seen
108 X posts from 100 X users, with an upper bound of 1,209,028 followers.
424 followers
312 followers
RT @patrickreville: @AaronGoodman33 I would probably favor 10 days decitabine if needing approved, non-trial option. Response to chemothera…
833 followers
@AaronGoodman33 I would probably favor 10 days decitabine if needing approved, non-trial option. Response to chemotherapy will be suboptimal and seems like venetoclax doesn't add efficacy https://t.co/UEBWcsizVA https://t.co/kZjOMCKIWd https://t.co/ntRPU15
1,386 followers
RT @obigriffith: At #NCIITCR18, @NCIDirector highlights @WUSTLmed paper from Welch et al (Ley lab) as example of practice changing findings…